Despite reports of a sickle cell patient being cured by gene therapy, columnist Oluwatosin Adesoye explains why she remains ...

Autolus Therapeutics, a UCL spinout company, has received authorisation from the UK Medicines and Healthcare products ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

It's no secret that our waistlines often expand in middle-age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing ...

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

Fingrut, MD, assistant professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center. Stem cell donations can be done in different ways ...

1 Affiliated Hospital of Shandong Second Medical University, Weifang, China 2 Department of Hematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, China Chimeric antigen receptor natural ...

The first-line treatment for Parkinson’s is levodopa ... The cells, known as human-induced pluripotent stem cells, are typically adult skin or blood cells that have been reprogrammed in a ...

1). ‘Big leap’ for Parkinson’s treatment: symptoms improve in stem-cells trials Tabar et al. 2 describe the outcome of a phase I clinical trial in which 12 people in the United States and ...

Autoimmune diseases occur when the body's immune system mistakenly attacks healthy cells, creating chronic inflammation and long-term damage. Conventional treatment simply targets symptoms ...

The study found that stem cell treatment improved motor function in ... to mature into different kinds of cells by reverting adult cells to an embryonic state. The team focused on individuals ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.